Home
Scholarly Works
Idarucizumab For Dabigatran Reversal: Updated...
Conference

Idarucizumab For Dabigatran Reversal: Updated Results Of The Re-verse Ad Study

Authors

Pollack CV; Reilly PA; van Ryn J; Eikelboom J; Glund S; Bernstein RA; Dubiel R; Huisman MV; Hylek EM; Kamphuisen PW

Volume

134

Pagination

pp. E714-E715

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Publication Date

December 20, 2016

Name of conference

Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium

Conference place

New Orleans, LA

Conference start date

November 12, 2016

Conference end date

November 16, 2016

Conference proceedings

CIRCULATION

Issue

25

ISSN

0009-7322

Contact the Experts team